OTC: NIMU

NON INVASIVE MONITORING SYSTEMS INC /FL/

CIK 0000720762 · Industrials · SIC 3760 · Guided Missiles & Space Vehicles

Micro Revenue $6K Assets $26K as of Aug 9, 2026

Non-Invasive Monitoring Systems, Inc. (together with its consolidated subsidiaries, the “Company,” “NIMS,” “we,” “us” or “our”) was incorporated under the laws of the State of Florida on July 16, 1980. The Company’s offices are located at 4400 Biscayne Boulevard, Miami, Florida, 33137 and its… About this business →

Each report below shows a 3-bullet preview. Free accounts read 3 full reports a month — narrative summary, section diffs, and EDGAR-cited quotes.

Sign up free

Want to see a complete report first? Today's free report (OLMA 10-Q) is open in full — no account needed.

8-K Filed Jul 30, 2026 · Period ending Jul 27, 2026

Summary not yet generated.

S-1 Filed Jul 20, 2026

Summary not yet generated.

Partner

Trade NIMU commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

8-K Filed Jul 2, 2026 · Period ending Jun 30, 2026

Summary not yet generated.

8-K Filed Jun 30, 2026 · Period ending Jun 30, 2026

Summary not yet generated.

8-K Filed Jun 26, 2026 · Period ending Jun 24, 2026

Summary not yet generated.

10-Q Filed May 14, 2026 · Period ending Mar 31, 2026

Summary not yet generated.

8-K Filed May 12, 2026 · Period ending May 7, 2026

Summary not yet generated.

8-K Filed Mar 12, 2026 · Period ending Mar 6, 2026

Summary not yet generated.

10-Q Filed Jan 30, 2026 · Period ending Oct 31, 2025

Summary not yet generated.

10-K Filed Jan 30, 2026 · Period ending Jul 31, 2025

Summary not yet generated.

10-K Filed Oct 25, 2024 · Period ending Jul 31, 2024

Summary not yet generated.

Latest financial statements

From 10-Q filed May 14, 2026 (period ending Mar 31, 2026). SEC XBRL (companyfacts) — not generated by the model.

SEC XBRL

Consolidated Statements of Operations (Unaudited)

Description Q1 ended Mar 31, 2026 Q1 ended Oct 31, 2025
Operating expenses:
General and administrative 0.1 0.03
Total operating expenses 0.1 0.03
Operating income (0.1) (0.03)
Interest expense 0.02 0.02
Net income (0.2) (0.04)
Basic earnings per share
Diluted earnings per share

Consolidated Balance Sheets (Unaudited)

Description Mar 31, 2026 Dec 31, 2025
Current assets:
Cash and equivalents 0.02 0.01
Prepaid expenses and other current assets
Total current assets 0.03 0.01
TOTAL ASSETS 0.03 0.01
Current liabilities:
Other current liabilities 1.2 1.0
Total current liabilities 1.2 1.0
Total liabilities 1.2 1.0
Shareholders' equity:
Common stock 1.5 1.5
Capital in excess of stated value 26.6 26.6
Retained earnings (deficit) (29.3) (29.1)
Total shareholders' equity (1.2) (1.0)
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY 0.03 0.01

Consolidated Statements of Cash Flows (Unaudited)

Description Q1 ended Mar 31, 2026 Q1 ended Oct 31, 2025
Operating Activities:
Net cash from operating activities (0.08) (0.02)
Financing Activities:
Net cash from financing activities 0.1 0.03
Net increase/(decrease) in cash 0.02

Amounts in millions USD; EPS as reported. Line labels are presentation-friendly mappings of filer XBRL tags — not a re-audit of the full statements. Use EDGAR for interactive notes and detail. Interactive statements & notes on EDGAR ↗

About NON INVASIVE MONITORING SYSTEMS INC /FL/

Source: Item 1 (Business) from the 10-K filed January 30, 2026. Description as filed by the company with the SEC.

Item
1. Business.

General

Non-Invasive
Monitoring Systems, Inc. (together with its consolidated subsidiaries, the “Company,” “NIMS,” “we,”
“us” or “our”) was incorporated under the laws of the State of Florida on July 16, 1980. The Company’s
offices are located at 4400 Biscayne Boulevard, Miami, Florida, 33137 and its telephone number is (305) 575-4200.

Company
Overview

Our
primary business previously consisted of research, development, manufacturing, marketing and sales of non-invasive, motorized, whole
body periodic acceleration (“WBPA”) platforms. These therapeutic acceleration platforms are intended as aids to temporarily
increase local circulation for temporary relief of minor aches and pains, produce local muscle relaxation and reduce morning stiffness.

In
May 2019, we effectively discontinued operations. The Company is a shell company as defined in Rule 12b-2 of the Exchange Act.

Products

We
currently have no inventory and do not have any of our products available for sale.